TuesdayApr 05, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key milestone: the company is actively recruiting participants for its upcoming feasibility study using Kernel Flow, Kernel’s quantitative neuroimaging technology (https://ibn.fm/9aSxc). “The feasibility study using Kernel Flow offers an opportunity for researchers and our study participants to quantifiably gather information on a psychedelic experience,” said Cybin…

Continue Reading

TuesdayApr 05, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an increase in mental health issues on the heels of the pandemic Mydecine is leveraging the psychedelic drugs market, the PTSD market, and healthcare IT markets – with potential growth across all avenues In the first year of the COVID-19 pandemic, the prevalence of anxiety and depression worldwide increased by 25%, according to a World Health Organization (“WHO”)…

Continue Reading

TuesdayApr 05, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Building Climate Change Solutions Through Utilities Analysis for Commercial Facilities

Correlate Infrastructure Partners is a provider of data analysis and scalable services to help commercial and industrial real estate owners meet carbon reduction goals while also improving their net operating income Carbon reduction is a significant part of the multi-national response to climate change concerns, and Correlate Infrastructure Partners is taking a site-specific approach to furthering goals established worldwide in 2015 The company has been known as Triccar, but its stockholders approved changing the company name and ticker symbol in February, with final approval from the SEC expected within the coming days The company’s efforts to redefine itself reflect its…

Continue Reading

MondayApr 04, 2022 1:40 pm

QualityStocksNewsBreaks – American Cannabis Partners Welcomes Accomplished Entrepreneur to Combine Strengths, Accelerate Expansions in the Cannabis Space

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, today announced its appointment of T.J. Dillashaw as its director of marketing and as a member of the company’s advisory board. Dillashaw’s experience includes being a successful franchisee and area developer for a rapidly-growing certified organic juice bar company, as well as bringing new retail business to a sports nutrition and functional energy beverage company, for which he serves in a leadership capacity for marketing and business development. “I am pleased to welcome T.J., a two-time mixed martial arts bantamweight champion and accomplished entrepreneur, to ACP,” said Stephen Jordan, ACP’s…

Continue Reading

MondayApr 04, 2022 11:37 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Appoints Former Tesla Exec to Global Manufacturing, Strategic Planning Head

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has promoted John Taylor to the role of senior vice president of Global Manufacturing and Strategic Planning; Taylor had been serving as vice president of manufacturing for Mullen since January. Throughout his career, Taylor has gained impressive experience, including the management of several plant start-ups and more than 12 vehicle launches in the United States and around the world. Taylor began his career with General Motors where he served as launch manager, operations manager, and machine and equipment manager, was involved with 11 major automotive vehicle launches. Taylor joined Tesla in…

Continue Reading

MondayApr 04, 2022 10:23 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Preps First Export Following Colombia’s New Export Regulations

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced that Colombia has completed its required regulations to allow cannabis companies operating in the country, including Flora Growth, to export THC and CBD dried flower. The country passed Resolution 539 on April 1, 2022, which is a regulatory checklist for companies; the resolution includes export quotas. The export steps included in the resolution outline adjustments to Flora’s approved 43.6-ton quota, which means the addition of dried flower can be included with FLGC’s existing purchase agreements from countries including Germany, Israel, Australia, South…

Continue Reading

MondayApr 04, 2022 9:30 am

American Cannabis Partners Helps Michigan Achieve Record Cannabis Sales

Michigan continues to break sales records in the cannabis sector ACP currently operates in Michigan and California and is exploring strategies for expanding operations to two more states The company is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations Cannabis sales numbers for December 2021 are in, and Michigan has broken another record (https://ibn.fm/pySD7). This is the kind of news that cannabis operators in the state, including American Cannabis Partners (“ACP”), love to hear. “Michigan closed out 2021 with another record-breaking month of adult-use marijuana sales in December, state officials say,”…

Continue Reading

MondayApr 04, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) CEO to Present at Three Upcoming Investor Conferences Spotlighting the Company’s Strategic Outlook for the Remainder of 2022

Delic Holdings Co-founder and CEO, Matt Stang, will take part in three upcoming conferences – the Scottdale Capital Event, the Planet MicroCap Showcase, and the H.C. Wainwright Annual Global Life Sciences Conference In presentations and one-on-one meetings, Stang will discuss Delic’s new revenue lines and strategic outlook for the remainder of the year During a recent interview on The Jesse Tee Show, Stang noted the company intends to scale its ketamine clinics as well as build infrastructure to accommodate expanded psychedelic healing  The company hopes to utilize its expanded infrastructure to help destigmatize mental health conditions  Delic Holdings (CSE: DELC)…

Continue Reading

MondayApr 04, 2022 9:15 am

Lightning Network Sees Increase in Popularity; LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Now Has Nine Active Nodes on the Network

The Lightning Network speeds up crypto transactions from around 7 per second (Bitcoin) to 1 million per second (Lightning Network protocol) The Lightning Network was in the news due to it being used by Canadian Prime Minister candidate Pierre Poilievre and the possible use for verification of Twitter users LQwD leverages the Network and provides a proprietary platform as a service (“PaaS”) offering that speeds up transaction times, is cost-effective and easy to use from anywhere in the world Despite recent ups and downs, the cryptocurrency market maintains a strong upward trend, being expected to reach U.S. $2.2 billion by…

Continue Reading

MondayApr 04, 2022 9:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC

The three-day event showcased CNS through corporate presentation, fireside chat, and live question and answer sessions  CNS has been granted both Orphan Drug Designation and Fast Track status from the FDA for Berubicin in 2020 and 2021, respectively CNS initiated a potentially pivotal global trial of Berubicin for recurrent Glioblastoma Multiforme (“GBM”) with the dosing of the first patients in the trial during 3Q 2021 At the end of 2021, CNS gained approval from swissethics to initiate trial sites in Switzerland for the global trial of Berubicin Virtual event participation can be found on the CNS website under “Events” CNS…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered